This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Development and Pre-clinical Evaluation of New 68Ga-NOTA-folate Conjugates for PET Imaging of Folate Receptor-positive Tumors
- A Folate Receptor-{alpha}-Specific Ligand That Targets Cancer Tissue and Not Sites of Inflammation
- Folic Acid Conjugates for Nuclear Imaging of Folate Receptor-Positive Cancer
- In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with 99mTc-Folate SPECT/CT
- Dendrimer-based nanoparticles for cancer therapy
- Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor-Positive Ovarian Cancer
- Folate Receptor-Specific Antitumor Activity of EC131, a Folate-Maytansinoid Conjugate
- Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer
- Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery
- Preclinical Evaluation of 99mTc-EC20 for Imaging Folate Receptor-Positive Tumors
- Differential Expression of Folate Receptor in Pituitary Adenomas
- Selective Delivery of CB300638, a Cyclopenta[g]quinazoline-based Thymidylate Synthase Inhibitor into Human Tumor Cell Lines Overexpressing the {alpha}-Isoform of the Folate Receptor
- Evaluation of 111In-DTPA-Folate as a Receptor-Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results
- An Analytic Dosimetry Study for the Use of Radionuclide-Liposome Conjugates in Internal Radiotherapy
- Expression of Folate Receptor Type {{alpha}} in Relation to Cell Type, Malignancy, and Differentiation in Ovary, Uterus, and Cervix
- Expression and Functional Characterization of the beta -Isoform of the Folate Receptor on CD34+ Cells
- Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors {alpha} and {beta}